164 related articles for article (PubMed ID: 36424174)
1. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
2. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Properties of Thrombus-Targeted Urokinase/Multi-Walled Carbon Nanotubes (MWCNTs)-Chitosan (CS)-RGD Drug Delivery System.
Zhang R; Luo S; Hao LK; Jiang YY; Gao Y; Zhang NN; Zhang XC; Song YM
J Biomed Nanotechnol; 2021 Sep; 17(9):1711-1725. PubMed ID: 34688316
[TBL] [Abstract][Full Text] [Related]
4. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
[TBL] [Abstract][Full Text] [Related]
5. Poly-
Chen S; Liang M; Wu C; Zhang X; Wang Y; Zhao M
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985552
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model.
Burke SE; Davidson DJ; Lubbers NL; Reininger IM; Henkin J
Thromb Res; 1996 Sep; 83(6):421-31. PubMed ID: 8885137
[TBL] [Abstract][Full Text] [Related]
7. Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.
Xie S; Mo C; Cao W; Xie S; Li S; Zhang Z; Li X
Acta Biomater; 2022 Apr; 142():49-59. PubMed ID: 35158079
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis.
Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y
Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic Biotaxi Solution Based on Blood Cell Membrane Cloaking Enables Fullerenol Thrombolysis
Chen K; Wang Y; Liang H; Xia S; Liang W; Kong J; Liang Y; Chen X; Mao M; Chen Z; Bai X; Zhang J; Li J; Chang YN; Li J; Xing G
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14958-14970. PubMed ID: 32142246
[TBL] [Abstract][Full Text] [Related]
10. Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy.
Xie S; Li S; Cao W; Mo C; Zhang Z; Huang K; Li X
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37553-37565. PubMed ID: 35948498
[TBL] [Abstract][Full Text] [Related]
11. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Propelled Janus Rod-Shaped Micromotors for Site-Specific Sonodynamic Thrombolysis.
Cao W; Liu Y; Ran P; He J; Xie S; Weng J; Li X
ACS Appl Mater Interfaces; 2021 Dec; 13(49):58411-58421. PubMed ID: 34846117
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
[TBL] [Abstract][Full Text] [Related]
14. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.
Chen Z; Yuan C; Ye Y; Lu B; Hu E; Lu F; Yu K; Xie R; Lan G
Carbohydr Polym; 2024 Mar; 328():121703. PubMed ID: 38220339
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
[TBL] [Abstract][Full Text] [Related]
17. GOx-Powered Janus Platelet Nanomotors for Targeted Delivery of Thrombolytic Drugs in Treating Thrombotic Diseases.
Fang X; Ye H; Shi K; Wang K; Huang Y; Zhang X; Pan J
ACS Biomater Sci Eng; 2023 Jul; 9(7):4302-4310. PubMed ID: 37307138
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
Collen D; Stassen JM; Verstraete M
J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
Kajimoto Y; Ohta T; Kuroiwa T
Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
